DAHP reduced the metastatic melanoma cell growth. WM983B melanoma cells were treated (DAHP) or not (NT) for 24, 48, 72 and 96 h with 1, 2 and 4 mM DAHP, and viable cells were evaluated by MTT (A) and for 9 days with 2 and 4 mM DAHP, and the formation of clones was visualized by a clonogenicity assay (B). Values are reported in the bar graphs and expressed as the means ± S.D. The experiments were performed in triplicate. p-values were based on a one-way ANOVA test, followed by Bonferroni’s post-test and two-way ANOVA test, followed by Bonferroni’s multiple comparisons test. *, p < 0.05; **, p < 0.01 and ***, p < 0.001.